This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University of Massachusetts. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shrewsbury, MA (US) (2021 - 2024)
- Boston, MA (US) (2024)
Company Filing History:
Years Active: 2021-2024
Title: Reka Agnes Haraszti: Innovator in Oligonucleotide Delivery
Introduction
Reka Agnes Haraszti is a prominent inventor based in Shrewsbury, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of oligonucleotide delivery. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents is titled "Bioactive conjugates for oligonucleotide delivery." This innovation features self-delivering oligonucleotides that are characterized by efficient RISC entry, minimal immune response, and off-target effects. Additionally, these oligonucleotides demonstrate efficient cellular uptake without the need for formulation and achieve specific tissue distribution. Another notable patent is "Artificial exosome composition and related methods." This patent provides novel artificial exosomes and methods for producing them, along with techniques for delivering cargo molecules to cells using these artificial exosomes.
Career Highlights
Reka Agnes Haraszti is affiliated with the University of Massachusetts, where she continues her research and development in biotechnology. Her work has garnered attention for its potential applications in therapeutic delivery systems.
Collaborations
Some of her notable coworkers include Anastasia Khvorova and Neil Aronin, who contribute to her research endeavors and collaborative projects.
Conclusion
Reka Agnes Haraszti is an influential inventor whose work in oligonucleotide delivery and artificial exosomes is shaping the future of biotechnology. Her patents reflect her commitment to advancing medical science and improving therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
